Login
$JCTC
$2.82 +$0.06 (2.17%) Close

Consolidated balance sheets

In millions of USD, except per-share amounts
Q3 FY2026
As of May 31, 2026
Q2 FY2026
As of Feb 28, 2026
Q1 FY2026
As of Nov 30, 2025
Q4 FY2025
As of Aug 31, 2025
Q3 FY2025
As of May 31, 2025
Q2 FY2025
As of Feb 28, 2025
Q1 FY2025
As of Nov 30, 2024
Q4 FY2024
As of Aug 31, 2024
Q3 FY2024
As of May 31, 2024
Q2 FY2024
As of Feb 29, 2024
Q1 FY2024
As of Nov 30, 2023
Q4 FY2023
As of Aug 31, 2023
Q3 FY2023
As of May 31, 2023
Q2 FY2023
As of Feb 28, 2023
Q1 FY2023
As of Nov 30, 2022
Q4 FY2022
As of Aug 31, 2022
Q3 FY2022
As of May 31, 2022
Q2 FY2022
As of Feb 28, 2022
Q1 FY2022
As of Nov 30, 2021
Q4 FY2021
As of Aug 31, 2021
ASSETS
Current assets
  Cash and cash equivalents
  Accounts receivable, net of allowance of $0 (August 31, 2025 - $0)
  Inventory, net of allowance of $719,573 (August 31, 2025 - $1,200,000) (note 3)
Assets held for sale (note 4)
  Prepaid expenses
  Prepaid income taxes
  Tariff refund receivable (note 12)
  Total current assets
Property, plant and equipment, net (note 4)
Intangible assets, net (note 5)
Deferred tax assets (Note 6)
  Total assets
Current liabilities
  Accounts payable
Notes payable
  Accrued liabilities
Deferred tax liability (note 6)
  Income taxes payable
  Total liabilities
Stockholders’ equity
Capital stock (notes 8, 9) Authorized 21,567,564 common shares, no par value 10,000,000 preferred shares, no par value Issued 3,520,113 common shares (August 31, 2025 – 3,518,119)
  Additional paid-in capital
  Retained earnings
  Total stockholders’ equity
  Total liabilities and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support